

HY-P99683 · 1 mg
MedChemExpress · Cat: HY-P99683
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ladiratuzumab-vedotin.html
Description
Ladiratuzumab vedotin SGN-LIV1A is a LIV-1 targeting antibody drug conjugate ADC IC50: 5.6 nM for LIV-1 . Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death ICD to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer.







